Obagi C Rx System C Therapy Night
Name: Obagi C Rx System C Therapy Night
- Obagi C Rx System C Therapy Night mg
- Obagi C Rx System C Therapy Night drug
- Obagi C Rx System C Therapy Night side effects
- Obagi C Rx System C Therapy Night effects of
Patient information
For Topical Use Only
Complete skin care regimen formulated with 4% hydroquinone to reduce hyperpigmentation and other essential ingredients to help address the signs of skin aging caused by photoaging.
Please read this product information prior to use of the Obagi-C® Rx System. Any questions regarding your particular skin care regimen should be directed to your physician. More information about the Obagi-C® Rx System or other Obagi systems is available at our website at www.obagi.com.
-106-10 Obagi-C® Rx System C-Clarifying Serum for Normal to Dry Skin
Each gram of Obagi-C® Rx System C-Clarifying Serum for Normal to Dry Skin contains:
Active:Hydroquinone, USP 4% (40 mg per g)
Inactives:ascorbic acid, propylene carbonate, propylene glycol, sodium lauryl sulfate, water
-122-10 Obagi-C® Rx System C-Clarifying Serum for Normal to Oily Skin
Each gram of Obagi-C® Rx System C-Clarifying Serum for Normal to Oily Skin contains:
Active:Hydroquinone, USP 4% (40 mg per g)
Inactives:ascorbic acid, dipropylene glycol, fragrance, propylene carbonate, propylene glycol, SD alcohol-39-C, sodium lauryl sulfate, water
Precautions
(See WARNINGS.)
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy
Pregnancy Category C
Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers
It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage
Safety and effectiveness in children, below the age of 12 years, have not been established.
Principal display panel c-therapy night cream
OBAGI-C® RX SYSTEM
NDC# 62032-105-36
C-THERAPY NIGHT CREAM
SKIN LIGHTENING CREAM
WITH VITAMIN C & E
HYDROQUINONE USP, 4%
RX ONLY
PM
Net wt. 2 oz. (57 g)
OBAGI-C RX SYSTEM C-THERAPY NIGHT hydroquinone cream | ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
|
Labeler - OMP, INC. (790553353) |
Registrant - VALEANT PHARMACEUTICALS NORTH AMERICA LLC (042230623) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Ei LLC | 105803274 | MANUFACTURE(62032-105) |
For Healthcare Professionals
Applies to hydroquinone topical: compounding powder, topical cream, topical emulsion, topical gel, topical solution
Dermatologic
Dermatologic side effects have included localized contact dermatitis. Exogenous ochronosis (involving over 10,000 exposures under careful clinical supervision) has been reported at an incidence of 22 cases in more than 50 years.[Ref]
Some side effects of Obagi-C Rx System C-Therapy Night Cream may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.